Fund Advisors of America Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fund Advisors of America Inc's BMY Position: Q2 2026 in Review
Fund Advisors of America Inc increased its Bristol-Myers Squibb (BMY) stake by 2.3% in Q2 2026, buying an estimated $6.09K and bringing the position to 4,786 shares worth $276K. The position accounts for 0.25% of the portfolio, ranked #90.
Fund Advisors of America Inc first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $284K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Fund Advisors of America Inc held 4,786 shares of Bristol-Myers Squibb worth $276K as of Q2 2026.
- Fund Advisors of America Inc bought 106 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.09K.
- Bristol-Myers Squibb made up 0.25% of Fund Advisors of America Inc's portfolio in Q2 2026, its #90 holding.
- Fund Advisors of America Inc first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Fund Advisors of America Inc's Bristol-Myers Squibb position peaked at $284K in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Fund Advisors of America Inc's 13F filing for Q2 2026, filed 11 Aug 2026.